Your Prostate MRI deserves a second look.

DeepView Imaging delivers AI-powered prostate MRI analysis for more confident treatment decisions.
FDA-cleared (US) • CE-Marked (EU) • UKCA-Certified (UK)
Prostate Cancer Patient, Wife and Dog

Why Men & Their Doctors Trust
DeepView Imaging

6
2
3
4
9
3.6
2.4
3.3
4.2
5.1
%

AI Diagnostic Accuracy

Approximately 8–25% higher than conventional MRI interpretation.
6
5
4
3
3

Regulatory Clearances

✓ FDA-Cleared (US)
✓ CE-Marked (EU)
✓ UKCA-Certified (UK)
1 in 8

Men Will Be Diagnosed

with prostate cancer, driving demand for reliable second-opinion MRI tools.
~
6
2
3
4
3
0
2
3
4
5

Minutes

from upload to analysis, delivering insights to support faster decisions.
After feeling unsure about my MRI results, I turned to DeepView Imaging for a second review. The AI analysis was clear, detailed and delivered within minutes. The 3D imaging helped me visualize the findings and discuss with my doctor. I recommend it to anyone seeking clarity and confidence in their diagnosis."
Geoff, DeepView Imaging Customer (January 22, 2026)

We Support Your Care Team

Prostate MRI decisions are often made through collaboration between you, your physicians, and your loves ones. DeepView Imaging provides an additional layer of AI-supported analysis designed to complement your doctor’s expertise, strengthening interpretation, communication, and confidence in your care plan.

Prostate Cancer Patient and Doctor
 25%-60%
of imaging interpretations change after
a second opinion
Prostate Cancer Patient and Doctor
AI tools help
doctors see
important details more clearly on Prostate MRI
Prostate Cancer Patient Happy Couple

Where Are You in Your Prostate Cancer Journey?

Whether you’ve just received difficult news or you’ve been monitoring your condition for years, DeepView Imaging AI-assisted reports provide insights that can help you and your care team make more confident decisions.

Prostate Cancer Patient on Phone

I Was Recently  Diagnosed

Before moving forward with biopsy, surgery, radiation, or another treatment plan, many patients want confirmation that nothing has been missed. DeepView Imaging provides an independent, AI-enhanced second review of your MRI.
How do I get started?

If you've had an MRI of your prostate, you can request a copy from your imaging center and upload it to our system analysis by our AI software. We'll provide a report back, with color overlays within approximately 30 minutes of submission.

Do I need a Contrast MRI?

No, contrast is not required. Our AI software works with a standard non-contrast MRI of the prostate, commonly called a bpMRI (Biparametric MRI).

If you already have a contrast-enhanced MRI (called an mpMRI or Multiparametric MRI), that works too. The mpMRI contains both contrast and non-contrast image sequences—our AI simply uses the non-contrast sequences that are already part of your study.

In short: We can analyze either type of prostate MRI, as long as it meets our acquisition parameters.

Do I need a referral?

No, a referral is not needed to use this service.  

All you need is a copy of your MRI, which you can request from your doctor or imaging center.

I'm Monitoring My Condition

You’ve already made it through the initial diagnosis and the first decisions. Now, you’re watching carefully. Even when your scans look stable, it’s natural to wonder whether subtle changes could be developing beneath the surface. DeepView Imaging provides an AI-enhanced review of your MRI to help identify meaningful changes and support ongoing discussions with your care team.
Can this detect subtle changes over time?

Yes. DeepView Imaging's AI-assisted analysis is designed to evaluate MRI images for patterns associated with clinically significant prostate cancer, including areas that may evolve gradually. When scans are reviewed at different time points, the goal is not only to identify obvious new lesions, but to detect subtle progression that may not immediately stand out.

Can this be used after I've had treatment?

It depends on the treatment—and importantly, when your MRI was taken.

Timing Matters

Treatment can temporarily change how prostate tissue appears on imaging, so your body needs time to heal before a new MRI will be useful.

The efficacy of our AI solution has been clinically validated pre-treatment, however, for post-treatment it is still under review and not yet clinically validated. With this in mind, we recommend the waiting periods below before obtaining your next MRI for analysis.

Treatments Under Review

If you've had one of these treatments, we recommend waiting at least 90 days before your MRI.

  • Focal laser ablation
  • Focal cryoablation

If you've had one of these treatments, we recommend waiting at least 120 days before your MRI.

  • Radiation therapy
  • Hormone therapy
  • Chemotherapy
  • Immunotherapy

When in Doubt

These guidelines are based on our current understanding; your physician can help you decide if and when it is appropriate for your situation and decide whether the results should be taken into consideration.

Will results be comparable between scans?

Yes. Reports are structured to support longitudinal review. That means each scan is analyzed using consistent criteria so you and your physician can compare findings over time in a clear and standardized way. Structured reporting reduces ambiguity and helps focus discussions on what has changed — and what has not.

Do I need a referral?

No, a referral is not needed to use this service.  

All you need is a copy of your MRI, which you can request from your doctor or imaging center.

Learn More

How It Works

The better way to launch and update your business
Intuitive Dashboard
Our dashboard provides a clear overview. Discover how our platform can transform to your operations.
Intuitive Dashboard
Our dashboard provides a clear overview. Discover how our platform can transform to your operations.
Intuitive Dashboard
Our dashboard provides a clear overview. Discover how our platform can transform to your operations.
Intuitive Dashboard
Our dashboard provides a clear overview. Discover how our platform can transform to your operations.
Team Member
Insight

Setting the Standard in AI-Driven Prostate Imaging

AI-Powered MRI Analysis
Advanced artificial intelligence trained specifically to detect clinically significant prostate cancer.
Validated Accuracy
93.6% AUROC performance (vs ~85% typically found via MRI) for identifying prostate cancer.
Regulatory-Cleared
Three major international regulatory clearnances including: FDA (U.S.) • CE (EU) • UKCA (UK)
Rapid Turnaround
AI-generated structured diagnostic report with 3D images delivered in just about 30 minutes.
Biopsy Trained Data
AI trained on thousands of MRI scans matched with confirmed pathology results.
Secure Digital Upload
HIPPA-complaint platform for direct MRI submission and physician-ready reporting.